These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 11363074)

  • 1. Abbott protease inhibitor lottery in January, CD4 under 50--registration now.
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2000 PWAs to get ritonavir via expanded access.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritonavir expanded access.
    GMHC Treat Issues; 1995 Dec; 9(12):8. PubMed ID: 11363000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abbott: major protest over lack of access.
    AIDS Treat News; 1995 May; (no 223):7. PubMed ID: 11362468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How 'bout that ritonavir?
    Notes Undergr; 1996 Jan; (no 31):5. PubMed ID: 11363356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lottery opens for Abbott protease drug.
    Baker R
    BETA; 1995 Dec; ():3. PubMed ID: 11363007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded access for experimental AIDS drugs.
    Barr D; Gilden D
    GMHC Treat Issues; 1995 Sep; 9(9):2. PubMed ID: 11362908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abbott agrees to implement a compassionate use program for Ritonavir.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):38. PubMed ID: 11362798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abbott agrees to expanded access for ritonavir.
    Baker R
    BETA; 1995 Sep; ():4. PubMed ID: 11362891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merck expanded access program August 11, 1995 deadline.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merck's protease inhibitor expanded access program now open.
    Smart T; Torres G
    GMHC Treat Issues; 1995; 9(7/8):10. PubMed ID: 11362649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abbott cancels arm of protease inhibitor trial.
    J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):37-8. PubMed ID: 11362729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritonavir (Abbott protease inhibitor) proves survival benefit in late-stage AIDS.
    James JS
    AIDS Treat News; 1996 Feb; (no 240):2-4. PubMed ID: 11363184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor expanded access.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):3. PubMed ID: 11362689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Europe out of step with the US.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):33-4. PubMed ID: 11363328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ritonavir: expanded access begins, warning on drug interactions.
    James JS
    AIDS Treat News; 1996 Jan; (no 239):4. PubMed ID: 11363086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABT-387/r early access program expanded further.
    Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merck protease inhibitor available to persons with CD4 count 50 or less--must register by August 11.
    AIDS Treat News; 1995 Jul; (no 227):1-2. PubMed ID: 11362618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.